Increased ischemic complications in fenestrated and branched endovascular abdominal aortic repair compared with standard endovascular aortic repair.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
07 2020
Historique:
received: 26 06 2019
accepted: 14 09 2019
pubmed: 23 2 2020
medline: 1 12 2020
entrez: 22 2 2020
Statut: ppublish

Résumé

Ischemic complications (including in the lower extremity, visceral, spinal, and pelvic territories) following standard endovascular aortic repair (EVAR) are well recognized but fortunately uncommon. The incidence of such complications following fenestrated and branched aortic repair (F/BEVAR) has not been well defined in the literature. The objective of this study was to compare the incidence of ischemic complications between EVAR and F/BEVAR and to elucidate potential risk factors for these complications. We identified all patients who underwent EVAR from 2003 to 2017 or F/BEVAR from 2012 to 2017 in the national Vascular Quality Initiative database. We assessed differences in perioperative ischemic outcomes with methods including logistic regression and inverse probability of treatment propensity score weighting, using a composite end point of lower extremity ischemia, intestinal ischemia, stroke, or new dialysis as the primary end point. The data comprised 35,379 EVAR patients and 3374 F/BEVAR patients. F/BEVAR patients were more likely to be female, have had previous aneurysm repairs, and be deemed unfit for open aneurysm repair; they were less likely to have ruptured aneurysms; and they had higher estimated blood losses, contrast volumes, and fluoroscopy and procedure times. The incidence of any ischemic event (7.7% vs 2.2%) as well as the incidences of the component end points of lower extremity ischemia (2.3% vs 1.0%), intestinal ischemia (2.7% vs 0.7%), stroke (1.5% vs 0.3%), and new hemodialysis (3.1% vs 0.4%) were all significantly increased (all P < .001) in F/BEVAR compared with standard EVAR. After propensity adjustment, F/BEVAR conferred increased odds of any ischemic complication (1.8), intestinal ischemia (2.0), lower extremity ischemia (1.3), new hemodialysis (10.2), and stroke (2.3). Rates of lower extremity ischemia, intestinal ischemia, new dialysis, and stroke each range from 0% to 1% for standard EVAR and 1% to 3% for F/BEVAR. The incidence of perioperative ischemic complications following F/BEVAR is significantly increased compared to EVAR. The real-world data in this study should help guide decision-making for surgeons and patients as well as serve as one metric for progress in device and technique development. Improvements in ischemic complications may come from continued technology development such as smaller sheaths, improved imaging to decrease procedure time and contrast volume, embolic protection, and increased operator skill with wire and catheter manipulation.

Identifiants

pubmed: 32081484
pii: S0741-5214(19)32536-4
doi: 10.1016/j.jvs.2019.09.044
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-43

Informations de copyright

Copyright © 2019 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Gregory G Westin (GG)

Division of Vascular and Endovascular Surgery, New York University Langone Health, New York, NY.

Caron B Rockman (CB)

Division of Vascular and Endovascular Surgery, New York University Langone Health, New York, NY.

Mikel Sadek (M)

Division of Vascular and Endovascular Surgery, New York University Langone Health, New York, NY.

Bhama Ramkhelawon (B)

Division of Vascular and Endovascular Surgery, New York University Langone Health, New York, NY.

Matthew R Cambria (MR)

Division of Vascular and Endovascular Surgery, New York University Langone Health, New York, NY.

Michele Silvestro (M)

Division of Vascular and Endovascular Surgery, New York University Langone Health, New York, NY.

Karan Garg (K)

Division of Vascular and Endovascular Surgery, New York University Langone Health, New York, NY.

Neal S Cayne (NS)

Division of Vascular and Endovascular Surgery, New York University Langone Health, New York, NY.

Frank J Veith (FJ)

Division of Vascular and Endovascular Surgery, New York University Langone Health, New York, NY.

Thomas S Maldonado (TS)

Division of Vascular and Endovascular Surgery, New York University Langone Health, New York, NY. Electronic address: thomas.maldonado@nyumc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH